Latest News : 2013

The NASDAQ welcomes Eckhard Podack, M.D., Ph.D., outside Times Square in New York City, as Heat Biologics makes its initial public offering.

U Innovation Celebrates First Public Offering of a University of Miami Spin-Off

U Innovation, home of technology advancement at the University of Miami, is celebrating the first initial public offering (IPO) by a company to evolve from its mission to bring life-enhancing discoveries made by UM scientists to the marketplace. The company, Heat Biologics (NASDAQ: HTBX), raised $27 million to fund clinical trials for its proprietary, unique off-the-shelf ImPACT (Immune Pan Antigen Cytotoxic Therapy) vaccines.

Read more »

Alberto R. Ramos, M.D., M.S.P.H., and Natasa Strbo, M.D., Ph.D.

CTSI Awards Career Development Grants to Two Junior Investigators

The Miami Clinical and Translational Science Institute (CTSI) has awarded grants to two Miller School researchers for its Mentored Translational Research Scholars Program (K12), which helps junior faculty become successful independent investigators

Read more »

Krishna V. Komanduri, M.D.

Research Uncovers Approach That May Decrease Complications of Stem Cell Transplants for Cancer

The preferred treatment of many high-risk or relapsed hematologic malignancies remains an allogeneic stem cell transplant. However, patients and physicians often face graft-versus-host disease (GVHD), a frequent and life-threatening complication. Miller School and Sylvester Comprehensive Cancer Center researchers have developed a method to decrease GVHD, while maintaining the benefits of T-cell virus-specific immunity.

Read more »

Lisa Plano, M.D., Ph.D.

Collaborative Studies Show Clear Link Between Human Bacteria and Ocean Environments

Two Miller School collaborative studies led by Lisa Plano, M.D., Ph.D., associate professor of pediatrics and microbiology and immunology, have shown a clear link between a common human bacterium and ocean environments. For the first time, UM researchers showed that levels of Staphylococcus aureus, commonly known as “staph,” vary in tidal waters and beach sand, based on the number of bathers.

Read more »

Eckhard Podack, M.D., Ph.D.

Hope for HIV Vaccine Found in Miller School Researcher’s SIV Study

Offering hope for an HIV vaccine, Eckhard Podack, M.D., Ph.D., professor and chair of microbiology and immunology, has demonstrated that a vaccine he developed with a novel heat-shock technology provides significant protection against the Simian Immunodeficiency Virus (SIV), a non-human virus closely related to the HIV virus that causes AIDS.

Read more »